Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Heydmann

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Gut|January 2, 2023
Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate targetEloi R Verrier, Gaëtan Ligat, Laura Heydmann, et al.
Hepatology (Baltimore, Md.)|July 31, 2015
A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D virusesEloi R Verrier, Che C Colpitts, Charlotte Bach, et al.
Nature Communications|June 3, 2020
A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factorCarla Eller, Laura Heydmann, Che C Colpitts, et al.
Gastroenterology|April 17, 2012
Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodiesIsabel Fofana, Samira Fafi-Kremer, Patric Carolla, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cellsXiaodong Zhuang, Senko Tsukuda, Florian Wrensch, et al.
Iscience|September 21, 2021
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cellsXiaodong Zhuang, Senko Tsukuda, Florian Wrensch, et al.
Gastroenterology|April 13, 2019
Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease DevelopmentJoachim Lupberger, Tom Croonenborghs, Armando Andres Roca Suarez, et al.
Science Translational Medicine|December 21, 2022
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticityNatascha Roehlen, Antonio Saviano, Houssein El Saghire, et al.
Nature Communications|September 18, 2021
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discoveryEmilie Crouchet, Simonetta Bandiera, Naoto Fujiwara, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Gut|January 2, 2023
Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate targetEloi R Verrier, Gaëtan Ligat, Laura Heydmann, et al.
Hepatology (Baltimore, Md.)|July 31, 2015
A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D virusesEloi R Verrier, Che C Colpitts, Charlotte Bach, et al.
Nature Communications|June 3, 2020
A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factorCarla Eller, Laura Heydmann, Che C Colpitts, et al.
Gastroenterology|April 17, 2012
Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodiesIsabel Fofana, Samira Fafi-Kremer, Patric Carolla, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cellsXiaodong Zhuang, Senko Tsukuda, Florian Wrensch, et al.
Iscience|September 21, 2021
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cellsXiaodong Zhuang, Senko Tsukuda, Florian Wrensch, et al.
Gastroenterology|April 13, 2019
Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease DevelopmentJoachim Lupberger, Tom Croonenborghs, Armando Andres Roca Suarez, et al.
Science Translational Medicine|December 21, 2022
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticityNatascha Roehlen, Antonio Saviano, Houssein El Saghire, et al.
Nature Communications|September 18, 2021
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discoveryEmilie Crouchet, Simonetta Bandiera, Naoto Fujiwara, et al.
Pageof 3